Centre Hospitalier Régional et Universitaire de Nancy
Citations 1
S4 Risankizumab Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomized Phase 3 INSPIRE Study
American Journal of Gastroenterology | December 14, 2023 | Volume: 118 | Issue: 12S | Pages: S2-S2